Logo image of AAB.CA

ABERDEEN INTERNATIONAL INC (AAB.CA) Stock Fundamental Analysis

TSX:AAB - Toronto Stock Exchange - CA0030691012 - Common Stock - Currency: CAD

0.035  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AAB. AAB was compared to 82 industry peers in the Capital Markets industry. AAB has a bad profitability rating. Also its financial health evaluation is rather negative. AAB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year AAB has reported negative net income.
AAB had a positive operating cash flow in the past year.
In multiple years AAB reported negative net income over the last 5 years.
In multiple years AAB reported negative operating cash flow during the last 5 years.
AAB.CA Yearly Net Income VS EBIT VS OCF VS FCFAAB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M -20M

1.2 Ratios

The Return On Assets of AAB (-174.80%) is worse than 91.46% of its industry peers.
Looking at the Return On Equity, with a value of -343.01%, AAB is doing worse than 87.80% of the companies in the same industry.
Industry RankSector Rank
ROA -174.8%
ROE -343.01%
ROIC N/A
ROA(3y)-110.61%
ROA(5y)-64.24%
ROE(3y)-173.73%
ROE(5y)-101.99%
ROIC(3y)N/A
ROIC(5y)N/A
AAB.CA Yearly ROA, ROE, ROICAAB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

1.3 Margins

In the last couple of years the Profit Margin of AAB has grown nicely.
In the last couple of years the Operating Margin of AAB has grown nicely.
AAB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y143.06%
OM growth 5Y20.6%
PM growth 3Y126.63%
PM growth 5Y18.38%
GM growth 3YN/A
GM growth 5YN/A
AAB.CA Yearly Profit, Operating, Gross MarginsAAB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100 200 300 400

More info and screens

3

2. Health

2.1 Basic Checks

AAB has more shares outstanding than it did 1 year ago.
AAB has more shares outstanding than it did 5 years ago.
AAB has a worse debt/assets ratio than last year.
AAB.CA Yearly Shares OutstandingAAB.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
AAB.CA Yearly Total Debt VS Total AssetsAAB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

2.2 Solvency

AAB has an Altman-Z score of -18.63. This is a bad value and indicates that AAB is not financially healthy and even has some risk of bankruptcy.
AAB's Altman-Z score of -18.63 is in line compared to the rest of the industry. AAB outperforms 42.68% of its industry peers.
AAB has a debt to FCF ratio of 0.62. This is a very positive value and a sign of high solvency as it would only need 0.62 years to pay back of all of its debts.
AAB has a better Debt to FCF ratio (0.62) than 85.37% of its industry peers.
AAB has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of AAB (0.01) is better than 78.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.62
Altman-Z -18.63
ROIC/WACCN/A
WACCN/A
AAB.CA Yearly LT Debt VS Equity VS FCFAAB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M 50M

2.3 Liquidity

AAB has a Current Ratio of 0.21. This is a bad value and indicates that AAB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of AAB (0.21) is worse than 89.02% of its industry peers.
AAB has a Quick Ratio of 0.21. This is a bad value and indicates that AAB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of AAB (0.21) is worse than 89.02% of its industry peers.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.21
AAB.CA Yearly Current Assets VS Current LiabilitesAAB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

AAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.09%, which is quite impressive.
AAB shows a strong growth in Revenue. In the last year, the Revenue has grown by 46.30%.
EPS 1Y (TTM)48.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.83%
Revenue 1Y (TTM)46.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-80.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AAB.CA Yearly Revenue VS EstimatesAAB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M -20M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AAB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AAB.CA Price Earnings VS Forward Price EarningsAAB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

AAB's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 82.31
EV/EBITDA N/A
AAB.CA Per share dataAAB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AAB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ABERDEEN INTERNATIONAL INC

TSX:AAB (6/13/2025, 7:00:00 PM)

0.035

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)12-12 2024-12-12
Earnings (Next)06-11 2025-06-11
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap5.59M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF 82.31
P/OCF 82.31
P/B 1.97
P/tB 1.97
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY1.21%
OCF(TTM)0
OCFY1.21%
SpS-0.05
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -174.8%
ROE -343.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM -0.83%
ROA(3y)-110.61%
ROA(5y)-64.24%
ROE(3y)-173.73%
ROE(5y)-101.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y143.06%
OM growth 5Y20.6%
PM growth 3Y126.63%
PM growth 5Y18.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover-1.46
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.62
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.21
Altman-Z -18.63
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)46.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-80.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y40.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y139.09%
FCF growth 3Y-53.83%
FCF growth 5YN/A
OCF growth 1Y139.09%
OCF growth 3Y-53.83%
OCF growth 5YN/A